secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2025-10-09T23:59:59+00:00
Accession:  0001104659-25-098354
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio board changes: Lisa Colleran resigns, Dr. Betty Jo Rocchio appointed
-----------------------------------------------------------------------------

- Lisa Colleran resigned from the board on Oct 4, 2025; no disagreement with company.
- Dr. Betty Jo Rocchio appointed effective Oct 9, 2025; she is EVP, Chief Executive Nurse at Advocate Health.
- Initial equity award: option for 17,550 shares vesting monthly over 3 years; RSU for 11,925 shares vesting annually over 3 years.
- Annual retainer $45,000; starting 2026: annual award of option for 11,700 shares and RSU for 7,950 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465925098354/0001104659-25-098354-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465925098354/tm2528308d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-098354

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer